nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLC22A1—prostate cancer	0.396	1	CbGaD
Latanoprost—SLCO2B1—Estrone—prostate cancer	0.169	0.399	CbGbCtD
Latanoprost—SLCO2B1—Conjugated Estrogens—prostate cancer	0.111	0.261	CbGbCtD
Latanoprost—SLCO2B1—Estradiol—prostate cancer	0.0973	0.229	CbGbCtD
Latanoprost—SLC22A1—Estradiol—prostate cancer	0.0471	0.111	CbGbCtD
Latanoprost—PTGFR—prostate gland—prostate cancer	0.00162	0.242	CbGeAlD
Latanoprost—Bimatoprost—AKR1C3—prostate cancer	0.00124	0.35	CrCbGaD
Latanoprost—PTGFR—urethra—prostate cancer	0.00109	0.162	CbGeAlD
Latanoprost—Iloprost—PDE4D—prostate cancer	0.00106	0.3	CrCbGaD
Latanoprost—Dinoprost Tromethamine—HPGDS—prostate cancer	0.00092	0.26	CrCbGaD
Latanoprost—SLCO2B1—prostate gland—prostate cancer	0.000895	0.133	CbGeAlD
Latanoprost—PTGFR—testis—prostate cancer	0.000715	0.107	CbGeAlD
Latanoprost—SLCO2B1—renal system—prostate cancer	0.00061	0.0909	CbGeAlD
Latanoprost—SLC22A1—renal system—prostate cancer	0.000583	0.0869	CbGeAlD
Latanoprost—PTGFR—lymph node—prostate cancer	0.000518	0.0772	CbGeAlD
Latanoprost—SLCO2B1—testis—prostate cancer	0.000394	0.0588	CbGeAlD
Latanoprost—Tafluprost—PTGS2—prostate cancer	0.000321	0.0908	CrCbGaD
Latanoprost—SLCO2B1—lymph node—prostate cancer	0.000286	0.0426	CbGeAlD
Latanoprost—Headache—Nilutamide—prostate cancer	0.000242	0.00191	CcSEcCtD
Latanoprost—Headache—Flutamide—prostate cancer	0.000241	0.0019	CcSEcCtD
Latanoprost—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00024	0.0019	CcSEcCtD
Latanoprost—Pain—Bicalutamide—prostate cancer	0.000238	0.00189	CcSEcCtD
Latanoprost—Erythema—Goserelin—prostate cancer	0.000238	0.00188	CcSEcCtD
Latanoprost—Oedema—Ethinyl Estradiol—prostate cancer	0.000236	0.00186	CcSEcCtD
Latanoprost—Erythema—Conjugated Estrogens—prostate cancer	0.000235	0.00186	CcSEcCtD
Latanoprost—Urinary tract infection—Estradiol—prostate cancer	0.000234	0.00185	CcSEcCtD
Latanoprost—Conjunctivitis—Estradiol—prostate cancer	0.000234	0.00185	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Mitoxantrone—prostate cancer	0.000234	0.00185	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—prostate cancer	0.000234	0.00185	CcSEcCtD
Latanoprost—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000231	0.00183	CcSEcCtD
Latanoprost—Stinging—Epirubicin—prostate cancer	0.000231	0.00183	CcSEcCtD
Latanoprost—Back pain—Goserelin—prostate cancer	0.00023	0.00182	CcSEcCtD
Latanoprost—Skin disorder—Ethinyl Estradiol—prostate cancer	0.000229	0.00181	CcSEcCtD
Latanoprost—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000229	0.00181	CcSEcCtD
Latanoprost—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000228	0.00181	CcSEcCtD
Latanoprost—Dizziness—Degarelix—prostate cancer	0.000228	0.0018	CcSEcCtD
Latanoprost—Back pain—Conjugated Estrogens—prostate cancer	0.000228	0.0018	CcSEcCtD
Latanoprost—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000227	0.0018	CcSEcCtD
Latanoprost—Vision blurred—Goserelin—prostate cancer	0.000224	0.00177	CcSEcCtD
Latanoprost—Hepatic function abnormal—Capecitabine—prostate cancer	0.000223	0.00177	CcSEcCtD
Latanoprost—Vision blurred—Conjugated Estrogens—prostate cancer	0.000222	0.00175	CcSEcCtD
Latanoprost—Urinary tract infection—Mitoxantrone—prostate cancer	0.000218	0.00173	CcSEcCtD
Latanoprost—Conjunctivitis—Mitoxantrone—prostate cancer	0.000218	0.00173	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Etoposide—prostate cancer	0.000218	0.00173	CcSEcCtD
Latanoprost—Rash—Degarelix—prostate cancer	0.000217	0.00172	CcSEcCtD
Latanoprost—Dermatitis—Degarelix—prostate cancer	0.000217	0.00172	CcSEcCtD
Latanoprost—Headache—Degarelix—prostate cancer	0.000216	0.00171	CcSEcCtD
Latanoprost—Eye pain—Capecitabine—prostate cancer	0.000216	0.00171	CcSEcCtD
Latanoprost—Dizziness—Cabazitaxel—prostate cancer	0.000215	0.0017	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—prostate cancer	0.000214	0.00169	CcSEcCtD
Latanoprost—Connective tissue disorder—Estradiol—prostate cancer	0.000213	0.00168	CcSEcCtD
Latanoprost—Headache—Cabazitaxel—prostate cancer	0.000204	0.00161	CcSEcCtD
Latanoprost—Lacrimation increased—Epirubicin—prostate cancer	0.000203	0.00161	CcSEcCtD
Latanoprost—Arthralgia—Goserelin—prostate cancer	0.000202	0.0016	CcSEcCtD
Latanoprost—Chest pain—Goserelin—prostate cancer	0.000202	0.0016	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000201	0.00159	CcSEcCtD
Latanoprost—Chest pain—Conjugated Estrogens—prostate cancer	0.0002	0.00158	CcSEcCtD
Latanoprost—Arthralgia—Conjugated Estrogens—prostate cancer	0.0002	0.00158	CcSEcCtD
Latanoprost—Discomfort—Goserelin—prostate cancer	0.0002	0.00158	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000199	0.00157	CcSEcCtD
Latanoprost—Pruritus—Bicalutamide—prostate cancer	0.000197	0.00156	CcSEcCtD
Latanoprost—Diplopia—Capecitabine—prostate cancer	0.000195	0.00154	CcSEcCtD
Latanoprost—Mediastinal disorder—Estradiol—prostate cancer	0.000195	0.00154	CcSEcCtD
Latanoprost—Oedema—Goserelin—prostate cancer	0.000194	0.00153	CcSEcCtD
Latanoprost—Inflammation—Epirubicin—prostate cancer	0.000193	0.00153	CcSEcCtD
Latanoprost—Oedema—Conjugated Estrogens—prostate cancer	0.000192	0.00152	CcSEcCtD
Latanoprost—Nervous system disorder—Goserelin—prostate cancer	0.00019	0.0015	CcSEcCtD
Latanoprost—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000188	0.00149	CcSEcCtD
Latanoprost—Erythema—Estradiol—prostate cancer	0.000188	0.00149	CcSEcCtD
Latanoprost—Skin disorder—Goserelin—prostate cancer	0.000188	0.00149	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—prostate cancer	0.000188	0.00149	CcSEcCtD
Latanoprost—Skin disorder—Conjugated Estrogens—prostate cancer	0.000187	0.00148	CcSEcCtD
Latanoprost—Dizziness—Bicalutamide—prostate cancer	0.000184	0.00146	CcSEcCtD
Latanoprost—Back pain—Estradiol—prostate cancer	0.000182	0.00144	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Docetaxel—prostate cancer	0.000181	0.00143	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—prostate cancer	0.000179	0.00141	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Goserelin—prostate cancer	0.000177	0.0014	CcSEcCtD
Latanoprost—Rash—Bicalutamide—prostate cancer	0.000176	0.00139	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Capecitabine—prostate cancer	0.000176	0.00139	CcSEcCtD
Latanoprost—Dermatitis—Bicalutamide—prostate cancer	0.000176	0.00139	CcSEcCtD
Latanoprost—Erythema—Mitoxantrone—prostate cancer	0.000175	0.00139	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000175	0.00138	CcSEcCtD
Latanoprost—Headache—Bicalutamide—prostate cancer	0.000175	0.00138	CcSEcCtD
Latanoprost—Dry eye—Epirubicin—prostate cancer	0.000173	0.00137	CcSEcCtD
Latanoprost—Dyspnoea—Goserelin—prostate cancer	0.000173	0.00137	CcSEcCtD
Latanoprost—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000171	0.00135	CcSEcCtD
Latanoprost—Back pain—Mitoxantrone—prostate cancer	0.00017	0.00134	CcSEcCtD
Latanoprost—Angina pectoris—Docetaxel—prostate cancer	0.00017	0.00134	CcSEcCtD
Latanoprost—Asthma—Capecitabine—prostate cancer	0.000169	0.00133	CcSEcCtD
Latanoprost—Pruritus—Ethinyl Estradiol—prostate cancer	0.000167	0.00132	CcSEcCtD
Latanoprost—Pain—Goserelin—prostate cancer	0.000166	0.00131	CcSEcCtD
Latanoprost—Vision blurred—Mitoxantrone—prostate cancer	0.000165	0.00131	CcSEcCtD
Latanoprost—Pain—Conjugated Estrogens—prostate cancer	0.000164	0.0013	CcSEcCtD
Latanoprost—Angina pectoris—Capecitabine—prostate cancer	0.000164	0.0013	CcSEcCtD
Latanoprost—Bronchitis—Capecitabine—prostate cancer	0.000162	0.00128	CcSEcCtD
Latanoprost—Arthralgia—Estradiol—prostate cancer	0.00016	0.00127	CcSEcCtD
Latanoprost—Chest pain—Estradiol—prostate cancer	0.00016	0.00127	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—prostate cancer	0.00016	0.00127	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000159	0.00126	CcSEcCtD
Latanoprost—Discomfort—Estradiol—prostate cancer	0.000158	0.00125	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000157	0.00124	CcSEcCtD
Latanoprost—Dizziness—Ethinyl Estradiol—prostate cancer	0.000156	0.00123	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—prostate cancer	0.000155	0.00123	CcSEcCtD
Latanoprost—Oedema—Estradiol—prostate cancer	0.000154	0.00122	CcSEcCtD
Latanoprost—Eczema—Epirubicin—prostate cancer	0.000151	0.0012	CcSEcCtD
Latanoprost—Mediastinal disorder—Etoposide—prostate cancer	0.000151	0.0012	CcSEcCtD
Latanoprost—Conjunctivitis—Docetaxel—prostate cancer	0.000151	0.00119	CcSEcCtD
Latanoprost—Nervous system disorder—Estradiol—prostate cancer	0.000151	0.00119	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—prostate cancer	0.00015	0.00119	CcSEcCtD
Latanoprost—Arthralgia—Mitoxantrone—prostate cancer	0.000149	0.00118	CcSEcCtD
Latanoprost—Chest pain—Mitoxantrone—prostate cancer	0.000149	0.00118	CcSEcCtD
Latanoprost—Skin disorder—Estradiol—prostate cancer	0.000149	0.00118	CcSEcCtD
Latanoprost—Rash—Ethinyl Estradiol—prostate cancer	0.000149	0.00118	CcSEcCtD
Latanoprost—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000148	0.00117	CcSEcCtD
Latanoprost—Discomfort—Mitoxantrone—prostate cancer	0.000148	0.00117	CcSEcCtD
Latanoprost—Headache—Ethinyl Estradiol—prostate cancer	0.000148	0.00117	CcSEcCtD
Latanoprost—Urinary tract infection—Capecitabine—prostate cancer	0.000146	0.00116	CcSEcCtD
Latanoprost—Conjunctivitis—Capecitabine—prostate cancer	0.000146	0.00116	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—prostate cancer	0.000144	0.00114	CcSEcCtD
Latanoprost—Oedema—Mitoxantrone—prostate cancer	0.000143	0.00113	CcSEcCtD
Latanoprost—Back pain—Etoposide—prostate cancer	0.000141	0.00112	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Estradiol—prostate cancer	0.00014	0.00111	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—prostate cancer	0.00014	0.00111	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—prostate cancer	0.000139	0.0011	CcSEcCtD
Latanoprost—Skin disorder—Mitoxantrone—prostate cancer	0.000139	0.0011	CcSEcCtD
Latanoprost—Pruritus—Goserelin—prostate cancer	0.000137	0.00109	CcSEcCtD
Latanoprost—Dyspnoea—Estradiol—prostate cancer	0.000137	0.00108	CcSEcCtD
Latanoprost—Connective tissue disorder—Docetaxel—prostate cancer	0.000137	0.00108	CcSEcCtD
Latanoprost—Pruritus—Conjugated Estrogens—prostate cancer	0.000136	0.00107	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—prostate cancer	0.000136	0.00107	CcSEcCtD
Latanoprost—Connective tissue disorder—Capecitabine—prostate cancer	0.000133	0.00105	CcSEcCtD
Latanoprost—Pain—Estradiol—prostate cancer	0.000131	0.00104	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.00013	0.00103	CcSEcCtD
Latanoprost—Dizziness—Goserelin—prostate cancer	0.000128	0.00101	CcSEcCtD
Latanoprost—Dyspnoea—Mitoxantrone—prostate cancer	0.000128	0.00101	CcSEcCtD
Latanoprost—Dizziness—Conjugated Estrogens—prostate cancer	0.000127	0.001	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—prostate cancer	0.000126	0.000995	CcSEcCtD
Latanoprost—Mediastinal disorder—Docetaxel—prostate cancer	0.000126	0.000994	CcSEcCtD
Latanoprost—Chest pain—Etoposide—prostate cancer	0.000124	0.000983	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000123	0.000976	CcSEcCtD
Latanoprost—Discomfort—Etoposide—prostate cancer	0.000123	0.000971	CcSEcCtD
Latanoprost—Pain—Mitoxantrone—prostate cancer	0.000122	0.000969	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000122	0.000968	CcSEcCtD
Latanoprost—Rash—Goserelin—prostate cancer	0.000122	0.000967	CcSEcCtD
Latanoprost—Dermatitis—Goserelin—prostate cancer	0.000122	0.000966	CcSEcCtD
Latanoprost—Mediastinal disorder—Capecitabine—prostate cancer	0.000122	0.000962	CcSEcCtD
Latanoprost—Headache—Goserelin—prostate cancer	0.000121	0.000961	CcSEcCtD
Latanoprost—Erythema—Docetaxel—prostate cancer	0.000121	0.00096	CcSEcCtD
Latanoprost—Rash—Conjugated Estrogens—prostate cancer	0.000121	0.000958	CcSEcCtD
Latanoprost—Dermatitis—Conjugated Estrogens—prostate cancer	0.000121	0.000957	CcSEcCtD
Latanoprost—Headache—Conjugated Estrogens—prostate cancer	0.00012	0.000952	CcSEcCtD
Latanoprost—Connective tissue disorder—Prednisone—prostate cancer	0.000118	0.000934	CcSEcCtD
Latanoprost—Erythema—Capecitabine—prostate cancer	0.000117	0.000929	CcSEcCtD
Latanoprost—Asthma—Epirubicin—prostate cancer	0.000117	0.000929	CcSEcCtD
Latanoprost—Back pain—Docetaxel—prostate cancer	0.000117	0.000928	CcSEcCtD
Latanoprost—Skin disorder—Etoposide—prostate cancer	0.000116	0.000915	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—prostate cancer	0.000114	0.000905	CcSEcCtD
Latanoprost—Back pain—Capecitabine—prostate cancer	0.000114	0.000899	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000113	0.000896	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—prostate cancer	0.000113	0.000893	CcSEcCtD
Latanoprost—Vision blurred—Capecitabine—prostate cancer	0.000111	0.000876	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000109	0.000863	CcSEcCtD
Latanoprost—Pruritus—Estradiol—prostate cancer	0.000109	0.00086	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—prostate cancer	0.000109	0.00086	CcSEcCtD
Latanoprost—Dyspnoea—Etoposide—prostate cancer	0.000106	0.00084	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—prostate cancer	0.000106	0.000837	CcSEcCtD
Latanoprost—Erythema—Prednisone—prostate cancer	0.000105	0.000828	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—prostate cancer	0.000104	0.000827	CcSEcCtD
Latanoprost—Chest pain—Docetaxel—prostate cancer	0.000103	0.000817	CcSEcCtD
Latanoprost—Arthralgia—Docetaxel—prostate cancer	0.000103	0.000817	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000103	0.000811	CcSEcCtD
Latanoprost—Pain—Etoposide—prostate cancer	0.000102	0.000806	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—prostate cancer	0.000102	0.000805	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—prostate cancer	0.000102	0.000805	CcSEcCtD
Latanoprost—Dizziness—Estradiol—prostate cancer	0.000102	0.000804	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000101	0.000799	CcSEcCtD
Latanoprost—Chest pain—Capecitabine—prostate cancer	0.0001	0.000791	CcSEcCtD
Latanoprost—Arthralgia—Capecitabine—prostate cancer	0.0001	0.000791	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.93e-05	0.000786	CcSEcCtD
Latanoprost—Oedema—Docetaxel—prostate cancer	9.9e-05	0.000783	CcSEcCtD
Latanoprost—Discomfort—Capecitabine—prostate cancer	9.88e-05	0.000782	CcSEcCtD
Latanoprost—Vision blurred—Prednisone—prostate cancer	9.86e-05	0.00078	CcSEcCtD
Latanoprost—Nervous system disorder—Docetaxel—prostate cancer	9.71e-05	0.000768	CcSEcCtD
Latanoprost—Rash—Estradiol—prostate cancer	9.69e-05	0.000767	CcSEcCtD
Latanoprost—Dermatitis—Estradiol—prostate cancer	9.68e-05	0.000766	CcSEcCtD
Latanoprost—Headache—Estradiol—prostate cancer	9.63e-05	0.000762	CcSEcCtD
Latanoprost—Skin disorder—Docetaxel—prostate cancer	9.61e-05	0.000761	CcSEcCtD
Latanoprost—Oedema—Capecitabine—prostate cancer	9.58e-05	0.000758	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—prostate cancer	9.42e-05	0.000745	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—prostate cancer	9.42e-05	0.000745	CcSEcCtD
Latanoprost—Nervous system disorder—Capecitabine—prostate cancer	9.4e-05	0.000744	CcSEcCtD
Latanoprost—Skin disorder—Capecitabine—prostate cancer	9.31e-05	0.000737	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—prostate cancer	9.23e-05	0.000731	CcSEcCtD
Latanoprost—Rash—Mitoxantrone—prostate cancer	9.03e-05	0.000714	CcSEcCtD
Latanoprost—Dermatitis—Mitoxantrone—prostate cancer	9.02e-05	0.000714	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.02e-05	0.000714	CcSEcCtD
Latanoprost—Headache—Mitoxantrone—prostate cancer	8.97e-05	0.00071	CcSEcCtD
Latanoprost—Arthralgia—Prednisone—prostate cancer	8.9e-05	0.000705	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.84e-05	0.0007	CcSEcCtD
Latanoprost—Dyspnoea—Docetaxel—prostate cancer	8.82e-05	0.000698	CcSEcCtD
Latanoprost—Discomfort—Prednisone—prostate cancer	8.8e-05	0.000696	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.73e-05	0.000691	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—prostate cancer	8.54e-05	0.000676	CcSEcCtD
Latanoprost—Dyspnoea—Capecitabine—prostate cancer	8.54e-05	0.000676	CcSEcCtD
Latanoprost—Oedema—Prednisone—prostate cancer	8.54e-05	0.000675	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—prostate cancer	8.47e-05	0.00067	CcSEcCtD
Latanoprost—Pain—Docetaxel—prostate cancer	8.46e-05	0.00067	CcSEcCtD
Latanoprost—Pruritus—Etoposide—prostate cancer	8.43e-05	0.000667	CcSEcCtD
Latanoprost—Nervous system disorder—Prednisone—prostate cancer	8.37e-05	0.000662	CcSEcCtD
Latanoprost—Skin disorder—Prednisone—prostate cancer	8.29e-05	0.000656	CcSEcCtD
Latanoprost—Pain—Capecitabine—prostate cancer	8.2e-05	0.000648	CcSEcCtD
Latanoprost—Erythema—Epirubicin—prostate cancer	8.18e-05	0.000647	CcSEcCtD
Latanoprost—Back pain—Epirubicin—prostate cancer	7.91e-05	0.000626	CcSEcCtD
Latanoprost—Dizziness—Etoposide—prostate cancer	7.88e-05	0.000623	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—prostate cancer	7.84e-05	0.00062	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Prednisone—prostate cancer	7.78e-05	0.000615	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—prostate cancer	7.71e-05	0.00061	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—prostate cancer	7.57e-05	0.000599	CcSEcCtD
Latanoprost—Rash—Etoposide—prostate cancer	7.51e-05	0.000594	CcSEcCtD
Latanoprost—Dermatitis—Etoposide—prostate cancer	7.5e-05	0.000594	CcSEcCtD
Latanoprost—Headache—Etoposide—prostate cancer	7.46e-05	0.00059	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—prostate cancer	7.32e-05	0.000579	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—prostate cancer	7.13e-05	0.000564	CcSEcCtD
Latanoprost—Pruritus—Docetaxel—prostate cancer	7e-05	0.000554	CcSEcCtD
Latanoprost—Arthralgia—Epirubicin—prostate cancer	6.96e-05	0.000551	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—prostate cancer	6.96e-05	0.000551	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.92e-05	0.000547	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—prostate cancer	6.88e-05	0.000544	CcSEcCtD
Latanoprost—Pruritus—Capecitabine—prostate cancer	6.78e-05	0.000536	CcSEcCtD
Latanoprost—Oedema—Epirubicin—prostate cancer	6.68e-05	0.000528	CcSEcCtD
Latanoprost—Nervous system disorder—Epirubicin—prostate cancer	6.55e-05	0.000518	CcSEcCtD
Latanoprost—Dizziness—Docetaxel—prostate cancer	6.55e-05	0.000518	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—prostate cancer	6.49e-05	0.000513	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—prostate cancer	6.44e-05	0.00051	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—prostate cancer	6.44e-05	0.00051	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.4e-05	0.000506	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—prostate cancer	6.37e-05	0.000504	CcSEcCtD
Latanoprost—Dizziness—Capecitabine—prostate cancer	6.34e-05	0.000501	CcSEcCtD
Latanoprost—Rash—Docetaxel—prostate cancer	6.24e-05	0.000494	CcSEcCtD
Latanoprost—Dermatitis—Docetaxel—prostate cancer	6.24e-05	0.000493	CcSEcCtD
Latanoprost—Headache—Docetaxel—prostate cancer	6.2e-05	0.000491	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—prostate cancer	6.18e-05	0.000489	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.08e-05	0.000481	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—prostate cancer	6.06e-05	0.000479	CcSEcCtD
Latanoprost—Rash—Capecitabine—prostate cancer	6.04e-05	0.000478	CcSEcCtD
Latanoprost—Pruritus—Prednisone—prostate cancer	6.04e-05	0.000478	CcSEcCtD
Latanoprost—Dermatitis—Capecitabine—prostate cancer	6.04e-05	0.000478	CcSEcCtD
Latanoprost—Headache—Capecitabine—prostate cancer	6e-05	0.000475	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—prostate cancer	6e-05	0.000475	CcSEcCtD
Latanoprost—Dyspnoea—Epirubicin—prostate cancer	5.95e-05	0.000471	CcSEcCtD
Latanoprost—Pain—Epirubicin—prostate cancer	5.71e-05	0.000452	CcSEcCtD
Latanoprost—Dizziness—Prednisone—prostate cancer	5.65e-05	0.000447	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.63e-05	0.000445	CcSEcCtD
Latanoprost—Dyspnoea—Doxorubicin—prostate cancer	5.51e-05	0.000436	CcSEcCtD
Latanoprost—Rash—Prednisone—prostate cancer	5.38e-05	0.000426	CcSEcCtD
Latanoprost—Dermatitis—Prednisone—prostate cancer	5.38e-05	0.000425	CcSEcCtD
Latanoprost—Headache—Prednisone—prostate cancer	5.35e-05	0.000423	CcSEcCtD
Latanoprost—Pain—Doxorubicin—prostate cancer	5.28e-05	0.000418	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—MC2R—prostate cancer	4.82e-05	0.00114	CbGpPWpGaD
Latanoprost—Pruritus—Epirubicin—prostate cancer	4.72e-05	0.000374	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—PTHLH—prostate cancer	4.68e-05	0.00111	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HAO1—prostate cancer	4.66e-05	0.0011	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—RXRA—prostate cancer	4.6e-05	0.00109	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKACB—prostate cancer	4.58e-05	0.00108	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CALCA—prostate cancer	4.54e-05	0.00107	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PPP3CA—prostate cancer	4.47e-05	0.00106	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL12—prostate cancer	4.44e-05	0.00105	CbGpPWpGaD
Latanoprost—Dizziness—Epirubicin—prostate cancer	4.42e-05	0.000349	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—ANXA1—prostate cancer	4.4e-05	0.00104	CbGpPWpGaD
Latanoprost—Pruritus—Doxorubicin—prostate cancer	4.37e-05	0.000346	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—PENK—prostate cancer	4.29e-05	0.00101	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	4.27e-05	0.00101	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	4.22e-05	0.000996	CbGpPWpGaD
Latanoprost—Rash—Epirubicin—prostate cancer	4.21e-05	0.000333	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—prostate cancer	4.21e-05	0.000333	CcSEcCtD
Latanoprost—Headache—Epirubicin—prostate cancer	4.18e-05	0.000331	CcSEcCtD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	4.13e-05	0.000975	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CALCA—prostate cancer	4.12e-05	0.000974	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GHR—prostate cancer	4.1e-05	0.000968	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—PIK3CA—prostate cancer	4.09e-05	0.000966	CbGpPWpGaD
Latanoprost—Dizziness—Doxorubicin—prostate cancer	4.09e-05	0.000323	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—PRKCQ—prostate cancer	4.05e-05	0.000956	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL12—prostate cancer	4.03e-05	0.000952	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	3.98e-05	0.000941	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NRP1—prostate cancer	3.93e-05	0.000928	CbGpPWpGaD
Latanoprost—Rash—Doxorubicin—prostate cancer	3.9e-05	0.000308	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—prostate cancer	3.89e-05	0.000308	CcSEcCtD
Latanoprost—Headache—Doxorubicin—prostate cancer	3.87e-05	0.000306	CcSEcCtD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	3.81e-05	0.0009	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADRB2—prostate cancer	3.81e-05	0.000899	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADI1—prostate cancer	3.8e-05	0.000897	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CBR1—prostate cancer	3.8e-05	0.000897	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PSAT1—prostate cancer	3.8e-05	0.000897	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TST—prostate cancer	3.8e-05	0.000897	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GRHL1—prostate cancer	3.8e-05	0.000897	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CSAD—prostate cancer	3.8e-05	0.000897	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—VAV3—prostate cancer	3.71e-05	0.000877	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—COMT—prostate cancer	3.7e-05	0.000873	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKCQ—prostate cancer	3.68e-05	0.000868	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	3.66e-05	0.000864	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VIP—prostate cancer	3.65e-05	0.000863	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GNRH1—prostate cancer	3.65e-05	0.000863	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ITPR1—prostate cancer	3.6e-05	0.00085	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GRP—prostate cancer	3.54e-05	0.000835	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LPAR1—prostate cancer	3.54e-05	0.000835	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UGT2B15—prostate cancer	3.53e-05	0.000834	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GRHPR—prostate cancer	3.53e-05	0.000834	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CKMT2—prostate cancer	3.53e-05	0.000834	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UGT2B17—prostate cancer	3.53e-05	0.000834	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.52e-05	0.000831	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PLCB2—prostate cancer	3.5e-05	0.000827	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LRP2—prostate cancer	3.5e-05	0.000827	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADRB2—prostate cancer	3.46e-05	0.000816	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CX3CL1—prostate cancer	3.43e-05	0.000811	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—P4HB—prostate cancer	3.43e-05	0.000811	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—VAV3—prostate cancer	3.37e-05	0.000796	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIST1H2BG—prostate cancer	3.37e-05	0.000796	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GRB7—prostate cancer	3.34e-05	0.000789	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDE4D—prostate cancer	3.34e-05	0.000789	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AOX1—prostate cancer	3.32e-05	0.000784	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NAGLU—prostate cancer	3.32e-05	0.000784	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—RFK—prostate cancer	3.32e-05	0.000784	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PGAM2—prostate cancer	3.32e-05	0.000784	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MBTPS1—prostate cancer	3.32e-05	0.000784	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM3—prostate cancer	3.32e-05	0.000784	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SULT2B1—prostate cancer	3.32e-05	0.000784	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ITPR1—prostate cancer	3.27e-05	0.000772	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIST1H4H—prostate cancer	3.25e-05	0.000769	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL8—prostate cancer	3.25e-05	0.000768	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	3.24e-05	0.000765	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—GNG5—prostate cancer	3.2e-05	0.000756	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GNG5—prostate cancer	3.18e-05	0.00075	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP3A43—prostate cancer	3.15e-05	0.000743	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AMACR—prostate cancer	3.15e-05	0.000743	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—DEGS1—prostate cancer	3.15e-05	0.000743	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NAT1—prostate cancer	3.15e-05	0.000743	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SRD5A2—prostate cancer	3.15e-05	0.000743	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD17B1—prostate cancer	3e-05	0.000709	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.79e-05	0.00066	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFBR1—prostate cancer	2.77e-05	0.000654	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTHLH—prostate cancer	2.77e-05	0.000654	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.73e-05	0.000645	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKR1C3—prostate cancer	2.72e-05	0.000643	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKACB—prostate cancer	2.71e-05	0.00064	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HPGD—prostate cancer	2.67e-05	0.000632	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—B4GALT4—prostate cancer	2.67e-05	0.000632	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—THBS1—prostate cancer	2.64e-05	0.000624	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PPP3CA—prostate cancer	2.64e-05	0.000624	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ANXA1—prostate cancer	2.6e-05	0.000615	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—MDM2—prostate cancer	2.58e-05	0.000609	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.57e-05	0.000608	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCZ—prostate cancer	2.55e-05	0.000603	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TNFRSF21—prostate cancer	2.51e-05	0.000594	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CG—prostate cancer	2.5e-05	0.00059	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PARP1—prostate cancer	2.47e-05	0.000583	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR4—prostate cancer	2.47e-05	0.000583	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.46e-05	0.00058	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP7B1—prostate cancer	2.45e-05	0.000578	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTAP—prostate cancer	2.45e-05	0.000578	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CALCA—prostate cancer	2.44e-05	0.000575	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SULT1E1—prostate cancer	2.38e-05	0.000563	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SRD5A1—prostate cancer	2.38e-05	0.000563	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL12—prostate cancer	2.38e-05	0.000562	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ACSL4—prostate cancer	2.27e-05	0.000537	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD17B3—prostate cancer	2.27e-05	0.000537	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CG—prostate cancer	2.27e-05	0.000535	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP9—prostate cancer	2.24e-05	0.000529	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CD—prostate cancer	2.19e-05	0.000518	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PHGDH—prostate cancer	2.18e-05	0.000515	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UMPS—prostate cancer	2.18e-05	0.000515	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ARG2—prostate cancer	2.18e-05	0.000515	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NGFR—prostate cancer	2.17e-05	0.000513	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCQ—prostate cancer	2.17e-05	0.000513	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.17e-05	0.000512	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAP3K7—prostate cancer	2.15e-05	0.000507	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LDHB—prostate cancer	2.14e-05	0.000505	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP3A5—prostate cancer	2.1e-05	0.000496	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF10—prostate cancer	2.06e-05	0.000487	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—RXRA—prostate cancer	2.06e-05	0.000487	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADRB2—prostate cancer	2.04e-05	0.000482	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PDHA1—prostate cancer	2.03e-05	0.000479	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UCP3—prostate cancer	2.03e-05	0.000479	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TCN2—prostate cancer	2.03e-05	0.000479	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA3—prostate cancer	2.03e-05	0.000479	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—JAK2—prostate cancer	2.01e-05	0.000476	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAP2K1—prostate cancer	2.01e-05	0.000474	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CD—prostate cancer	1.99e-05	0.000471	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VAV3—prostate cancer	1.99e-05	0.00047	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—MDM2—prostate cancer	1.98e-05	0.000467	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFBR2—prostate cancer	1.96e-05	0.000464	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD3B1—prostate cancer	1.93e-05	0.000457	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC22A3—prostate cancer	1.93e-05	0.000457	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ITPR1—prostate cancer	1.93e-05	0.000456	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CB—prostate cancer	1.91e-05	0.000452	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TBXAS1—prostate cancer	1.85e-05	0.000438	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA4—prostate cancer	1.85e-05	0.000438	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1R—prostate cancer	1.85e-05	0.000436	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL8—prostate cancer	1.84e-05	0.000434	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—JAK2—prostate cancer	1.83e-05	0.000432	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA2—prostate cancer	1.81e-05	0.000427	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SULT1A1—prostate cancer	1.78e-05	0.000422	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCG5—prostate cancer	1.78e-05	0.000422	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LPL—prostate cancer	1.77e-05	0.000418	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2—prostate cancer	1.76e-05	0.000415	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFRB—prostate cancer	1.75e-05	0.000414	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTA1—prostate cancer	1.74e-05	0.000412	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CB—prostate cancer	1.74e-05	0.00041	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD3B2—prostate cancer	1.72e-05	0.000407	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NAT2—prostate cancer	1.72e-05	0.000407	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTO1—prostate cancer	1.72e-05	0.000407	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ITGB3—prostate cancer	1.71e-05	0.000404	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL8—prostate cancer	1.67e-05	0.000394	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB3—prostate cancer	1.66e-05	0.000392	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR2—prostate cancer	1.66e-05	0.000391	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLCB2—prostate cancer	1.65e-05	0.00039	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2C18—prostate cancer	1.65e-05	0.00039	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LRP2—prostate cancer	1.65e-05	0.00039	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—P4HB—prostate cancer	1.62e-05	0.000383	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2—prostate cancer	1.6e-05	0.000377	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TERT—prostate cancer	1.59e-05	0.000375	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.58e-05	0.000372	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SULT2A1—prostate cancer	1.54e-05	0.000363	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIF1A—prostate cancer	1.52e-05	0.000359	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MED12—prostate cancer	1.51e-05	0.000357	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GNG5—prostate cancer	1.5e-05	0.000354	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LEP—prostate cancer	1.48e-05	0.00035	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CAV1—prostate cancer	1.47e-05	0.000347	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KDR—prostate cancer	1.45e-05	0.000343	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA3—prostate cancer	1.44e-05	0.000341	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ESR1—prostate cancer	1.42e-05	0.000335	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BAD—prostate cancer	1.38e-05	0.000327	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HPGDS—prostate cancer	1.38e-05	0.000325	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2C19—prostate cancer	1.37e-05	0.000323	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CG—prostate cancer	1.34e-05	0.000316	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APC—prostate cancer	1.34e-05	0.000316	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—prostate cancer	1.34e-05	0.000316	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ACHE—prostate cancer	1.34e-05	0.000316	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGF—prostate cancer	1.32e-05	0.000313	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IRS1—prostate cancer	1.32e-05	0.000313	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2A6—prostate cancer	1.32e-05	0.000312	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GSK3B—prostate cancer	1.28e-05	0.000304	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKR1C3—prostate cancer	1.28e-05	0.000304	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PRKACB—prostate cancer	1.28e-05	0.000302	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—INS—prostate cancer	1.27e-05	0.000299	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP17A1—prostate cancer	1.26e-05	0.000299	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.25e-05	0.000296	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CREBBP—prostate cancer	1.24e-05	0.000293	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1—prostate cancer	1.23e-05	0.00029	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—prostate cancer	1.22e-05	0.000288	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA2—prostate cancer	1.21e-05	0.000285	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAP2K1—prostate cancer	1.18e-05	0.00028	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CD—prostate cancer	1.18e-05	0.000278	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—prostate cancer	1.17e-05	0.000275	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SERPINE1—prostate cancer	1.16e-05	0.000275	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KRAS—prostate cancer	1.15e-05	0.000272	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC5A5—prostate cancer	1.15e-05	0.000272	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF2—prostate cancer	1.13e-05	0.000266	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2E1—prostate cancer	1.12e-05	0.000265	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—prostate cancer	1.11e-05	0.000263	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NQO1—prostate cancer	1.11e-05	0.000262	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TH—prostate cancer	1.09e-05	0.000259	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP3A4—prostate cancer	1.08e-05	0.000256	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JAK2—prostate cancer	1.08e-05	0.000255	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1B1—prostate cancer	1.06e-05	0.000252	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—prostate cancer	1.06e-05	0.00025	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MDM2—prostate cancer	1.05e-05	0.000249	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB2—prostate cancer	1.04e-05	0.000246	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GGT1—prostate cancer	1.03e-05	0.000244	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CB—prostate cancer	1.03e-05	0.000242	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA1—prostate cancer	1.02e-05	0.00024	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP19A1—prostate cancer	1e-05	0.000236	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL8—prostate cancer	9.86e-06	0.000233	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—RXRA—prostate cancer	9.66e-06	0.000228	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1B—prostate cancer	9.63e-06	0.000227	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—prostate cancer	9.53e-06	0.000225	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—prostate cancer	9.44e-06	0.000223	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2—prostate cancer	9.42e-06	0.000223	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—prostate cancer	9.38e-06	0.000221	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—COMT—prostate cancer	9.31e-06	0.00022	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—prostate cancer	9.26e-06	0.000219	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCND1—prostate cancer	9.19e-06	0.000217	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ITPR1—prostate cancer	9.11e-06	0.000215	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CTNNB1—prostate cancer	9.1e-06	0.000215	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—prostate cancer	8.92e-06	0.000211	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1A—prostate cancer	8.89e-06	0.00021	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTEN—prostate cancer	8.87e-06	0.000209	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—prostate cancer	8.65e-06	0.000204	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TYMS—prostate cancer	8.61e-06	0.000203	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—prostate cancer	8.51e-06	0.000201	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EP300—prostate cancer	8.46e-06	0.0002	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LPL—prostate cancer	8.35e-06	0.000197	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SRC—prostate cancer	8.22e-06	0.000194	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1A1—prostate cancer	8.07e-06	0.000191	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—prostate cancer	8.01e-06	0.000189	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ERCC2—prostate cancer	8e-06	0.000189	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—prostate cancer	7.93e-06	0.000187	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—prostate cancer	7.52e-06	0.000178	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARA—prostate cancer	7.38e-06	0.000174	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—prostate cancer	7.37e-06	0.000174	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—prostate cancer	7.35e-06	0.000174	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—prostate cancer	7.21e-06	0.00017	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAV1—prostate cancer	6.94e-06	0.000164	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KRAS—prostate cancer	6.81e-06	0.000161	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CG—prostate cancer	6.32e-06	0.000149	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—prostate cancer	6.25e-06	0.000148	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—prostate cancer	6.05e-06	0.000143	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—INS—prostate cancer	5.98e-06	0.000141	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CREBBP—prostate cancer	5.86e-06	0.000138	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CD—prostate cancer	5.56e-06	0.000131	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—prostate cancer	5.54e-06	0.000131	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—prostate cancer	5.25e-06	0.000124	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—prostate cancer	5.11e-06	0.000121	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CB—prostate cancer	4.84e-06	0.000114	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—prostate cancer	4.8e-06	0.000113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTEN—prostate cancer	4.18e-06	9.89e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—EP300—prostate cancer	3.99e-06	9.43e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—prostate cancer	2.95e-06	6.97e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—prostate cancer	2.41e-06	5.7e-05	CbGpPWpGaD
